Health Catalyst HCAT 深 滬
等待開盤 05-30 09:30:00 美东时间
1.38
-0.020
-1.43%
華盛通- 最 高1.42
- 今 開1.37
- 成交量 51.25万股
- 最 低 1.351
- 昨 收 1.40
- 總市值 10.20万
- 52周最高 4.2908
- 市盈率 靜 --
- 換手率 0.69%
- 52周最低 0.9551
- 委 比 35.16%
- 總股本 7.39万
- 歷史最高 59.50
- 量 比 0.95
- 振 幅 4.93%
- 歷史最低 0.9551
- 每 手 1
- 風險率 0.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Health Catalyst Earnings Call Maps Costly Transition
Health Catalyst (($HCAT)) has held its Q1 earnings call. Read on for the main h...
05-13 08:27
Stephens & Co. Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $1.75
Stephens & Co. analyst Jeff Garro maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight and lowers the price target from $2 to $1.75.
05-12 21:35
电话会总结 ｜ Health Catalyst(HCAT)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Health Catalyst 2026年第一季度业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 总营收7,080万美元，超出指导区间上限（6,800-7,000万美元） - 技术营收4,950万美元 - 专业服务营收2,130万美元 **盈利能力：** - 调整后毛利率51.5% - 调整后技术毛利率65.3% - 调整后专业服务毛利率19.4% - 调整后EBITDA 910万美元，超出指导区间（700-800万美元） - 调整后每股净收益0.02美元（加权平均股数7,260万股） **成本控制：** -
05-12 12:33
Cantor Fitzgerald Suspends Health Catalyst
Cantor Fitzgerald analyst Sarah James suspends Health Catalyst (NASDAQ:HCAT)
05-11 21:23
Earnings Scheduled For May 11, 2026
Companies Reporting Before The Bell • United Parks & Resorts (NYSE:PRKS) is...
05-11 19:11
Health Catalyst Q1 2026 Earnings Preview
Health Catalyst (HCAT) is scheduled to announce Q1 earnings results on Monday, May 11th, after market close. The consensus EPS Estimate is $0.02 (+100.0% Y/Y) and the consensus Revenue Estimate is $69...
05-11 05:35
Health Catalyst Eliminates Chief People Officer Role, Cuts ~9% Workforce, Or ~100 Positions, Under Cost-Reduction Initiative 'Project Nexus'
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 24, 2026, the Board of Directors (our Board) of Health
04-27 21:08
Health Catalyst CEO Retirement Accelerated With Advisory Role
Health Catalyst ( ($HCAT) ) has shared an announcement. On February 12, 2026, H...
04-03 18:38
Health Catalyst pays ex-CEO Burton $10,000 monthly under strategic adviser transition agreement
Health Catalyst pays ex-CEO Burton $10,000 monthly under strategic adviser transition agreement Health Catalyst entered transition agreement dated March 31, 2026 for former CEO Daniel Burton to serve as strategic advisor through Dec. 31, 2026. Agreement sets average monthly base salary at $0.01 mill
04-03 18:01
